Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar gilboy7 (< 20) Submitted: 11/1/2008 8:10:17 PM : Outperform Start Price: $50.02 CVD Score: -46.84

way oversold

Featured Broker Partners


Advertisement